Clover Health Investments, Corp. (NASDAQ:CLOV) Short Interest Update

Clover Health Investments, Corp. (NASDAQ:CLOV) saw a large increase in short interest in the month of December. As of December 31st, there was short interest totalling 15,960,000 shares, an increase of 9.0% from the December 15th total of 14,640,000 shares. Based on an average daily volume of 6,180,000 shares, the days-to-cover ratio is presently 2.6 days.

Wall Street Analyst Weigh In

A number of analysts recently issued reports on the company. Craig Hallum started coverage on Clover Health Investments in a research note on Tuesday, December 17th. They set a “buy” rating and a $6.00 price objective on the stock. UBS Group started coverage on Clover Health Investments in a research note on Monday, October 7th. They issued a “neutral” rating and a $4.00 target price on the stock.

Hedge Funds Weigh In On Clover Health Investments

A number of hedge funds and other institutional investors have recently modified their holdings of the company. Concurrent Investment Advisors LLC purchased a new stake in Clover Health Investments in the 3rd quarter worth approximately $28,000. Sigma Planning Corp purchased a new stake in Clover Health Investments in the 3rd quarter worth approximately $29,000. Parallax Volatility Advisers L.P. purchased a new stake in Clover Health Investments in the 3rd quarter worth approximately $38,000. Vanguard Personalized Indexing Management LLC lifted its holdings in Clover Health Investments by 54.4% in the 2nd quarter. Vanguard Personalized Indexing Management LLC now owns 34,372 shares of the company’s stock worth $42,000 after buying an additional 12,104 shares during the period. Finally, Realta Investment Advisors bought a new position in shares of Clover Health Investments in the 3rd quarter worth approximately $44,000. 19.77% of the stock is currently owned by hedge funds and other institutional investors.

Clover Health Investments Trading Up 0.2 %

CLOV opened at $4.08 on Friday. The stock has a 50-day moving average price of $3.36 and a 200-day moving average price of $3.00. Clover Health Investments has a 12-month low of $0.61 and a 12-month high of $4.71. The stock has a market capitalization of $2.04 billion, a P/E ratio of -20.40 and a beta of 1.95.

Clover Health Investments (NASDAQ:CLOV) last posted its quarterly earnings data on Wednesday, November 6th. The company reported ($0.02) earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of ($0.03) by $0.01. Clover Health Investments had a negative return on equity of 25.46% and a negative net margin of 5.92%. The firm had revenue of $330.99 million during the quarter, compared to analysts’ expectations of $347.60 million. During the same period in the prior year, the business earned ($0.09) EPS. On average, equities research analysts predict that Clover Health Investments will post -0.12 EPS for the current year.

Clover Health Investments Company Profile

Clover Health Investments, Corp. provides medicare advantage plans in the United States. It operates through two segments: Insurance and Non-Insurance. It also offers Clover Assistant, a cloud-based software platform, that enables physicians to detect, identify, and manage chronic diseases earlier; and access to data-driven and personalized insights for the patients they treat.